Dr. Miranda Gogishvili, a medical oncologist at the High Technology Medical Center, University Clinic in Tbilisi, Georgia, ...
What was once 25 treatments over five weeks can now often be delivered in 16 treatments, or even as few as five fractions.
Bleomycin-associated pulmonary toxicity complicated ABVD, contributed to PCP pneumonia, and impeded regimen completion, ...
In a recent interview with CURE, Prentiss emphasized that the current "wait and see" approach to lymphedema is failing ...
Incidence and mortality are rising in cohorts born after the 1950s, with three-quarters of colorectal cancers under 50 diagnosed at advanced stage, limiting curability. Preventable mortality is ...
Nuvalent seeks FDA approval of neladalkib for TKI-pretreated advanced ALK-positive NSCLC, leveraging ALKOVE-1 results demonstrating activity in extracranial disease and brain metastases. ALKOVE-1 ...
Candidate profiles include HCC, liver metastases, and hepatic adenomas, including multifocal disease and stage IV patients who might otherwise be excluded from liver-directed interventions. Outpatient ...
Discover how modern immunotherapy awakens T cells to shrink melanoma tumors, tracked by PET scans and used after surgery to prevent relapse. In this segment, Dr. Morrison provides clinical context ...
Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.
In this segment, Dr. Gregory Vidal discusses the role of estrogen receptor antagonists in the treatment of ER-positive, ...
In this segment, Dr. Gregory Vidal discusses how initial treatment options are selected for patients with ER-positive, ...
In this segment, Dr. Gregory Vidal discusses practical steps patients can take to manage side effects while undergoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results